Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients

被引：12

作者：

Aitmehdi, Raphael ^{[1
]}

Arnaud, Laurent ^{[6
,7
]}

Frances, Camille ^{[1
]}

Senet, Patricia ^{[1
]}

Monfort, Jean-Benoit ^{[1
]}

de Risi-Pugliese, Tullia ^{[1
]}

Barbaud, Annick ^{[1
]}

Cohen-Aubart, Fleur ^{[2
]}

Haroche, Julian ^{[2
]}

Pha, Micheline ^{[2
]}

Hie, Miguel ^{[2
]}

Le Guern, Veronique ^{[3
]}

Costedoat-Chalumeau, Nathalie ^{[3
]}

Mekinian, Arsene ^{[4
,5
]}

Fain, Olivier ^{[4
,5
]}

Mathian, Alexis ^{[2
]}

Amoura, Zahir ^{[2
]}

Chasset, Francoir ^{[1
]}

机构：

[1] Sorbonne Univ, Paris, France

[2] Grp Hosp Pitie Salpetriere, Hop Tenon, Fac Med, Serv Dermatol & Allergol, Paris, France

[3] UMRS, Ctr Immunol & Malad Infect, French Natl Referral Ctr Syst Lupus Erythematosus, Inst E3M,Inserm,Serv Med Interne 2,Internal Med D, Paris, France

[4] Univ Paris, Referral Ctr Rare Autoimmune & Syst Dis, Cochin Hosp, INSERM,U1153,Ctr Epidemiol & Stat,Sorbonne Paris, Paris, France

[5] Sorbonne Univ, Fac Med, Paris, France

[6] Hop St Antoine, Serv Med Interne, Paris, France

[7] Univ Strasbourg, Ctr Natl References Malad Syst & Autoimmunes Rare, Hop Univ Strasbourg, Serv Rhumatol, Strasbourg, France

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 84卷 / 04期

关键词：

RISK;

D O I：

10.1016/j.jaad.2020.11.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1171 / 1174

页数：4

共 5 条

[1] The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus [J].

Albrecht, J ;

Taylor, L ;

Berlin, JA ;

Dulay, S ;

Ang, G ;

Fakharzadeh, S ;

Kantor, J ;

Kim, E ;

Militello, G ;

McGinnis, K ;

Richardson, S ;

Treat, J ;

Vittorio, C ;

Van Voorhees, A ;

Werth, VP .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) :889-894

[2] Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare [J].

Braunstein, Inbal ;

Goodman, Noah G. ;

Rosenbach, Misha ;

Okawa, Joyce ;

Shah, Asha ;

Krathen, Michael ;

Kovarik, Carrie L. ;

Prak, Eline Luning ;

Werth, Victoria P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) :571-582

[3] Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study [J].

Cesbron, Elise ;

Bessis, Didier ;

Jachiet, Marie ;

Lipsker, Dan ;

Cordel, Nadege ;

Bouaziz, Jean-David ;

Bagot, Martine ;

Arnaud, Laurent ;

Barbaud, Annick ;

Frances, Camille ;

Chasset, Francois .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) :162-165

[4] Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus [J].

Cortes-Hernandez, Josefina ;

Avila, Gabriela ;

Vilardell-Tarres, Miquel ;

Ordi-Ros, Josep .

ARTHRITIS RESEARCH & THERAPY, 2012, 14 (06)

[5] Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients [J].

Fennira, Feriel ;

Chasset, Francois ;

Soubrier, Martin ;

Cordel, Nadege ;

Petit, Antoine ;

Frances, Camille .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (06) :1248-+

← 1 →